Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF-β1 haploinsufficiency
Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming gro...
Saved in:
Published in | Carcinogenesis (New York) Vol. 28; no. 12; pp. 2589 - 2596 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.12.2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0143-3334 1460-2180 |
DOI | 10.1093/carcin/bgm136 |
Cover
Abstract | Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming growth factor-β (TGF-β) 1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in vitro studies have shown that TGF-β1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-β1 and Ras has not been studied in in vivo tumorigenesis. We hypothesized that inactivation of TGF-β1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-β1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-β1+/+, K-ras LA (wild-type (WT)/LA) and TGF-β1+/−, K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared with WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared with HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-β1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-β1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-β1 responsiveness in addition to Ras mutation. |
---|---|
AbstractList | Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming growth factor-β (TGF-β) 1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in vitro studies have shown that TGF-β1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-β1 and Ras has not been studied in in vivo tumorigenesis. We hypothesized that inactivation of TGF-β1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-β1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-β1+/+, K-ras LA (wild-type (WT)/LA) and TGF-β1+/−, K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared with WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared with HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-β1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-β1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-β1 responsiveness in addition to Ras mutation. Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is required to bring about classical characteristics of cancer including angiogenesis as a prelude to invasion and metastasis. Transforming growth factor-β (TGF-β) 1 is a tumor suppressor gene that is implicated in lung cancer progression. Although in vitro studies have shown that TGF-β1 and Ras pathways cooperate during tumorigenesis, the biology of interaction of TGF-β1 and Ras has not been studied in in vivo tumorigenesis. We hypothesized that inactivation of TGF-β1 in addition to oncogeneic activation of K-ras would lead to early initiation and faster progression to lung adenocarcinoma and invasion and metastasis. Heterozygous (HT) TGF-β1 mice were mated with latent activatable (LA) mutated K-ras mice to generate TGF-β1+/+ , K-ras LA (wild-type (WT)/LA) and TGF-β1+/− , K-ras LA (HT/LA) mice. Both HT/LA and WT/LA mice developed spontaneous lung tumors, but HT/LA mice progressed to adenocarcinomas significantly earlier compared with WT/LA mice. In addition, WT/LA adenocarcinomas had significantly higher angiogenic activity compared with HT/LA adenocarcinomas. Thus, while oncogenic K-ras mutation and insensitivity to the growth regulatory effects of TGF-β1 is essential for initiation and progression of mouse lung tumors to adenocarcinoma, a full gene dosage of TGF-β1 is required for tumor-induced angiogenesis and invasive potential. This study identifies a number of genes not previously associated with lung cancer that are involved in tumor induction and progression. In addition, we provide evidence that progression to invasive angiogenic lesions requires TGF-β1 responsiveness in addition to Ras mutation. |
Author | Kang, Yang Jacks, Tyler Angdisen, Jerry Naumova, Alena Mercer, Kim L. Jakowlew, Sonia B. Pandey, Jyotsna Umphress, Sarah M. |
Author_xml | – sequence: 1 givenname: Jyotsna surname: Pandey fullname: Pandey, Jyotsna organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA – sequence: 2 givenname: Sarah M. surname: Umphress fullname: Umphress, Sarah M. organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA – sequence: 3 givenname: Yang surname: Kang fullname: Kang, Yang organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA – sequence: 4 givenname: Jerry surname: Angdisen fullname: Angdisen, Jerry organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA – sequence: 5 givenname: Alena surname: Naumova fullname: Naumova, Alena organization: Cell and Cancer Biology Branch, National Cancer Institute, 9610 Medical Center Drive, Suite 300, Rockville, MD 20850, USA – sequence: 6 givenname: Kim L. surname: Mercer fullname: Mercer, Kim L. organization: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA – sequence: 7 givenname: Tyler surname: Jacks fullname: Jacks, Tyler organization: Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA – sequence: 8 givenname: Sonia B. surname: Jakowlew fullname: Jakowlew, Sonia B. email: jakowles@mail.nih.gov organization: E-mail: jakowles@mail.nih.gov |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19914562$$DView record in Pascal Francis |
BookMark | eNpFkMFOAjEURRuDiYgu3c_GxE2lb0oLXRoiYMCYEEyMm6Z0OlCFdtLOGNn4UX6I3-TAEF295N5z3uKeo5bzziB0BeQWiKBdrYK2rrtcbYHyE9SGHic4hQFpoTaBHsWU0t4ZOo_xjRDglIk2-nr0WbVRpfUu8XlSVlsfEuuySh8i5bKkCH4VTIxHxDvtV8ZZnUxxUBEXPtrSfpjGjbWclGtTWyYap81eWYxH-OcbkrUqNt66WOW51bZudxfoNFebaC6Pt4OeR_eL4QTPnsYPw7sZttCHEoMeZJoYYCQjKRGw5JRoasQAhEozA7nRjGrGORWZGTBgIk_TPiNKUcI5T2kHXTd_CxW12uRBOW2jLILdqrCTIAT02IG7aThfFf8tkft9ZbOvbPatUdygNpbm8w9W4V3yPu0zOXl5lXMxnU9nMJRj-gujpIL9 |
CODEN | CRNGDP |
ContentType | Journal Article |
Copyright | Published by Oxford University Press 2007. 2007 2008 INIST-CNRS |
Copyright_xml | – notice: Published by Oxford University Press 2007. 2007 – notice: 2008 INIST-CNRS |
DBID | BSCLL IQODW |
DOI | 10.1093/carcin/bgm136 |
DatabaseName | Istex Pascal-Francis |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2180 |
EndPage | 2596 |
ExternalDocumentID | 19914562 10.1093/carcin/bgm136 ark_67375_HXZ_R9KRKL1C_G |
GroupedDBID | --- -E4 .2P .I3 .ZR 0R~ 18M 1TH 29B 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6J9 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPQP ABPTD ABQLI ABVGC ABWST ABXVV ABXZS ABZBJ ACGFO ACGFS ACNCT ACPRK ACUFI ACUTJ ACUTO ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEJOX AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFRAH AGINJ AGKEF AGQPQ AGQXC AGSYK AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN ARIXL ASPBG ATGXG AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSCLL BSWAC BTRTY BVRKM C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ESTFP F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z N9A NGC NLBLG NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROX ROZ RUSNO RW1 RXO SV3 TEORI TJX TLC TR2 W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 .55 .GJ 3O- 6.Y AAPGJ AASNB AAWDT ABEFU ABQTQ ABSAR ABSMQ ACFRR ACMRT ACPQN ACZBC ADJQC ADRIX AEKPW AFSHK AFXEN AFYAG AGKRT AGMDO ANFBD APJGH AQDSO AQKUS ASAOO ATDFG ATTQO AVNTJ BZKNY CXTWN DFGAJ EIHJH ELUNK FRP KC5 M49 MBLQV MBTAY O~Y QBD RHF RIG RNI RZF RZO TCN TMA X7M XOL ZGI ZKB ZXP ABIME ABPIB ABZEO ACVCV ADMTO AEHUL AFFQV AGORE AHGBF AJDVS IQODW OBFPC |
ID | FETCH-LOGICAL-i171t-1c8dc0e150d02091b630c3e9819a2de1fec53c56639de85159f22750aa3066623 |
ISSN | 0143-3334 |
IngestDate | Mon Jul 21 09:13:36 EDT 2025 Wed Aug 28 03:24:21 EDT 2024 Sat Sep 20 11:02:04 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | K ras Gene Induction C-Onc gene Modulation Loss of heterozygosity Tumor progression Tumor Transforming growth factor β1 Onc gene Carcinogenesis Protooncogene |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-i171t-1c8dc0e150d02091b630c3e9819a2de1fec53c56639de85159f22750aa3066623 |
Notes | istex:630F140DB47EEE400D5588481DD57E25FF06EC74 ark:/67375/HXZ-R9KRKL1C-G |
PageCount | 8 |
ParticipantIDs | pascalfrancis_primary_19914562 oup_primary_10_1093_carcin_bgm136 istex_primary_ark_67375_HXZ_R9KRKL1C_G |
PublicationCentury | 2000 |
PublicationDate | 2007-12-00 |
PublicationDateYYYYMMDD | 2007-12-01 |
PublicationDate_xml | – month: 12 year: 2007 text: 2007-12-00 |
PublicationDecade | 2000 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford |
PublicationTitle | Carcinogenesis (New York) |
PublicationYear | 2007 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
SSID | ssj0016359 |
Score | 1.925578 |
Snippet | Oncogenic K-ras is one of the most common genetic alterations in human lung adenocarcinomas. In addition, inactivation of clusters of tumor suppressor genes is... |
SourceID | pascalfrancis oup istex |
SourceType | Index Database Publisher |
StartPage | 2589 |
SubjectTerms | Biological and medical sciences Carcinogenesis, carcinogens and anticarcinogens Medical sciences Tumors |
Title | Modulation of tumor induction and progression of oncogenic K-ras-positive tumors in the presence of TGF-β1 haploinsufficiency |
URI | https://api.istex.fr/ark:/67375/HXZ-R9KRKL1C-G/fulltext.pdf |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQlxFuUxGYrxU3uI4l-YRqm2FUoSmViq8RI7tlAmWVG2KgAd-FD-EX8CP4fjSNB2dNHiJoshO3ZwvORd_5xyEnkU8kTHNJBEeD0kQJJIkfsYJjSJP5iDz2OzgD99G_XHwehJOWq3fDdbSssr2xfeteSX_I1W4BnLVWbL_INn6pnABzkG-cAQJw_FSMh6W0nXfMlv9yzNDLpdL1_7blAAop5bpaoaUhSjhbqeiMyBzviCWsvVF2bmLFelxZnKShAknjI6PyF7vcO-lTzsf-exzqdnrpu6ETtps2rY93Zao0PdXusrJRpufOtzwTgetbZfkb2W1KGqtMDawsi3cTZi6M9yvtYELar_nTs-auMVUby7Z1BI1d2zmVfwiPscFuSAvciPkyQhjLuSp7Gc6iDwCxonX_I773SZe_eZXObRtipyGB48v2qo9bGUtYZ4WnGTTM8q21Ok-pz9rViOff9I0uThM-5MP6UkyOBm8ob30-Aq66sdg2WmT_dWg3uMCUy-xBFv7_1wFWFjEgV3CgV0AuE36jf-6SsG8MeMLeH9z23ilYQ2NbqGbzo3BLywmb6OWKu6ga0NH1LiLfqyhicscG3jhGpoYQIAb0NRDamjiTWjauQuYjAGaeAVNPUVD89dPiv-G5T00Pjoc9frEtfogpzSmFaGiK4WnwDuR4L8kNIuYJ5hKwF7lvlQ0VyJkAlwPlkjV1TZ47uvOBJwz7YD77D7aKcpCPUA4k-BFREmc-ywIeDficS6Yr-IuqHWhQtlGz83jTGe2nEt6kdja6Ck873qYZWuw1MomtbJpo90NaaxHg9-lgwsPL_trj9D19dvxGO1U86V6AvZule0a2PwBku6yTw |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modulation+of+tumor+induction+and+progression+of+oncogenic+K-ras-positive+tumors+in+the+presence+of+TGF-%CE%B21+haploinsufficiency&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Pandey%2C+Jyotsna&rft.au=Umphress%2C+Sarah+M.&rft.au=Kang%2C+Yang&rft.au=Angdisen%2C+Jerry&rft.date=2007-12-01&rft.pub=Oxford+University+Press&rft.issn=0143-3334&rft.eissn=1460-2180&rft.volume=28&rft.issue=12&rft.spage=2589&rft.epage=2596&rft_id=info:doi/10.1093%2Fcarcin%2Fbgm136&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_HXZ_R9KRKL1C_G |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon |